Innate Pharma News and Activities

Presence

Innate Pharma develops immunotherapy medicines for cancer. Its products and services include antibody-based treatments and clinical development programs for healthcare providers, research partners, and patients.

Innate Pharma products and services overview:

Cancer immunotherapy
Antibody therapies
Drug development
Clinical research

Revenue: ~$25 million

Employees: 180

Headquarters: Marseille, France

Innate Pharma is one of the...

Innate Pharma is a company listed under the stock ticker IPH (FR).

Executives

View the org chart displaying its 24 main executives

Most searched biographies at Innate Pharma

Popular executive movements at Innate Pharma

Eric Vivier who is Senior Vice President and Chief Scientific Officer, will become Advisor on Jan. 1, 2026 (posted on September 17 2025).
Yannis Morel who is Executive Vice President and Chief Operating Officer, will become Executive Vice President, Chief Operating Officer and Chief Scientific Officer on Jan. 1, 2026 (posted on September 17 2025).

Create your alert
to follow the executive moves at Innate Pharma.